preview

Apoptosis And Suicide Synthesis Essay

Good Essays

The process of cell programming to commit suicide is also known as Apoptosis, it also is sometimes characterized by different characteristics and energy mechanisms. Apoptosis is too be considered as a very important part of different processes which mean proper development, cell-death, immune system, and many other programs that are vital to the human body. Research will continue to focus on the clearing up of the power of cell death. Also research will continue to seek how someone may be able to control the process of Apoptosis. “Scientist are also at the moment trying to learn how to modulate apoptosis, so they may be able to control programmed cell death”(2016).The process normally will occur during the aging of someone or just natural …show more content…

Cell death relates to brain diseases which can be organized by the loss of neurons. Caspases are also involved in Huntington’s disease which is the result of a mutation in the huntingtin protein. “Several human papilloma viruses or (HPV) have been implicated in the causing of cervical cancer. One of them produces a protein that binds and inactivates the apoptosis promoter”(Source 2) “Cancer is an example where the normal mechanisms of cell cycle regulation are dysfunctional”(Source 6).Many cancer cells could secrete different molecules that could completely avoid apoptosis. “Increased apoptosis in diseased cells is a characteristic of AIDs, Alzheimer’s and Parkinson's disease”(Source 6). “There is a variety of molecular mechanisms that tumor cells use to suppress apoptosis”(Source 6). Viruses coming from many different families stop apoptosis of …show more content…

Anti-cancer drugs and radiation are an example that work by triggering programmed cell death in diseased cells. I believe that understanding how to take control of apoptosis could become one of the first steps to treating many different conditions. The past decade has witnessed tremendous advances in the discovery and development of novel small-molecule inhibitors targeting apoptosis pathways for cancer treatment, with some compounds now in clinical development. Early promising clinical data have been reported with the new classes of anticancer drugs. This review covers the recent advancements in the development of small-molecule inhibitors targeting three major classes of antiapoptotic proteins: antiapoptotic B cell lymphoma 2, proteins, inhibitor of apoptosis proteins (IAPs), and murine double-minute 2 (MDM2). A Lot of attention is given to those that have been advanced into clinical trials. The challenges and future directions in the further preclinical and clinical development of these new anticancer drugs are also talked

Get Access